Merck Millipore, the life science division of Merck, today released MILLIPLEX® Analyst 5.1 for analysis and interpretation of Luminex®bead-based assay results

• Enables more rapid and efficient management, tracking, and analysis of multiplex assays
• Provides superior quality of fit, autofit, and potency calculation compared to other Luminex software packages
• Relational database functionality enables analysis of multiple files from different experiments

The new release, developed exclusively for Merck Millipore by VigeneTech, Inc. (Carlisle, MA), includes unique features such as autofit and potency calculation and offers superior quality of data reduction analytics compared to other Luminex® software packages. Superior algorithms yield better data at the low- and high-end of the standard curve. The autofit feature saves time by automatically using the best curve fit method for the curve presented. The potency calculation feature compares two or more standard curves, giving researchers a choice when reducing their data.

Data acquisition and analysis integrates seamlessly with all Luminex® instruments, including MAGPIX®, Luminex 200™ and FLEXMAP 3D® systems. MILLIPLEX® Analyst 5.1 is available as one-, five- and ten-seat licenses, enabling complete flexibility for small, medium, and large laboratories.

MILLIPLEX® Analyst 5.1 is accessed using a code flash drive making it possible to use the software on multiple systems. More user-friendly plate set-up means there are no limitations to where the standard curve can be put on the plate. Other software requires the standard curve to be placed vertically in the first column.

"MILLIPLEX® Analyst 5.1 software delivers a new level of data analysis for bead-based multiplex assays," describes John Sweeney, Head of the Bioscience Business Unit. "New features and increased ease-of-use enable faster, more effective data analysis and interpretation which further enhances the power and utility of multiplex assays. And with the relational database, researchers can compare standard curves and data over a period of time, not just from one particular day's work."

VigeneTech, who has been partnering with Merck Millipore on MILLIPLEX® Analyst software since 2008, is a recognized leader in the development of software solutions for complex image and data analysis.

For more information, please visit www.millipore.com.

About Merck Millipore

Merck Millipore is the life science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the life science tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.

Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2011 revenues of EUR 2.4 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.

Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany